GENE ID: ENSDARG00000028098

Symbol Location Gene type Genome version Species
fut9d 8: 13503377 ~ 13505486 (+) protein_coding GRCz11 Danio rerio

  • PPI (protein-protein interaction) results are shown above.
  • Green is ENSDARG00000028098 (fut9d), yellow represents other genes.
  • Hover over the node can see the symbol/gene ID it represents.
  • The more connections, the bigger symbol size.


    • MARKER



    EXPRESSION

    Dataset ID Tissue / Organ Experiment type Sample Cell type Marker class Evidence
    GSE158142 (2dpf) head baseline 2dpf, untreatment Eye (cluster: 15)
    		 marker
    		 DOI:10.1016/j.neuron.2020.09.023
    GSE158142 (3dpf) head baseline 3dpf, untreatment Periderm cells (cluster: 9)
    		 marker
    		 DOI:10.1016/j.neuron.2020.09.023
    PRJNA554650 (6.5dpf) brain baseline 6.5dpf, whole brain of nr1d1:VNP fish Cranial ganglion (cluster: 22)
    		 potential marker
    		 NA
    GSE158142 (5dpf) brain, eye baseline 5dpf, untreatment Eye (cluster: 13)
    		 potential marker
    		 NA
    GSE158849 (labeled) embryo baseline 6hpf, WT, 4sUTP injected (labeled) Enveloping layer cells (cluster: 7)
    		 potential marker
    		 NA
    PRJNA564810 (5dpf) embryo baseline 5dpf, a single-cell transcriptome atlas for zebrafish development Periderm cells (cluster: 4)
    		 potential marker
    		 NA
    PRJNA564810 (2dpf) embryo baseline 2dpf, a single-cell transcriptome atlas for zebrafish development Epidermal cells (cluster: 13)
    		 potential marker
    		 NA
    PRJNA564810 (1dpf) embryo baseline 1dpf, a single-cell transcriptome atlas for zebrafish development Epidermal cells (cluster: 14)
    		 potential marker
    		 NA
    GSE158142 (12hpf) head baseline 12hpf, 6 somites, untreatment Periderm cells (cluster: 17)
    		 potential marker
    		 NA
    GSE158142 (18hpf) head baseline 18hpf, 18 somites, untreatment Periderm cells (cluster: 17)
    		 potential marker
    		 NA
    GSE158142 (20hpf) head baseline 20hpf, 21-22 somites, untreatment Periderm cells (cluster: 11)
    		 potential marker
    		 NA
    GSE158142 (24hpf) head baseline 24hpf, untreatment Periderm cells (cluster: 8)
    		 potential marker
    		 NA
    GSE150498 (wildtype, 1X DSS) intestine disease 6dpf, wildtype, 1X DSS
    PRJNA605021 (supporting cells) neuromast baseline 7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[Et(krt4:EGFP)sqgw57A] transgenic zebrafish larvae Support cells (cluster: 2)
    		 potential marker
    		 NA
    PRJNA605021 (hair cells) neuromast baseline 7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[myo6b:actb1-EGFP] transgenic zebrafish larvae Support cells (cluster: 4)
    		 potential marker
    		 NA
    PRJNA668529 (3d) olfactory rosette disease 3mpf, intranasal 100ng r-Spike 3 days Neuronal progenitor (cluster: 16)
    		 potential marker
    		 NA
    GSE158142 (8dpf) brain, eye baseline 8dpf, untreatment
    PRJNA610520 (4.5dpf) caudal hematopoietic tissue baseline 4.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells.
    PRJNA610520 (3.5dpf) caudal hematopoietic tissue baseline 3.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells.
    GSE144944 (fgfr3 -|-) cranial vault growth 1mpf, fgfr3 -/-
    GSE144944 (fgfr3 +|+) cranial vault baseline 1mpf, fgfr3 +/+
    GSE168695 (5dpf) embryo baseline 5dpf, GFP+ cells isolated from 5 dpf cldnb:lyn-EGFP embryos
    PRJNA734348 (shield, control) embryo baseline 6hpf, shield, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV)
    GSE106587 (WT) embryo baseline 12hpf, 6 somites, wild-type TLAB embryo
    GSE158849 (unlabeled) embryo baseline 6hpf, WT, 4sUTP injected (unlabeled)
    PRJNA734348 (shield, dnmt1) embryo growth 6hpf, shield, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV)
    PRJNA734348 (dome, control) embryo baseline 4.3hpf, dome, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV)
    GSE173972 (WT, ezh1+|+) embryo baseline 1.25dpf, Kdrl-positive embryos
    PRJNA640816 (2.9dpf) embryo baseline 2.9dpf, FACS isolated -4.9sox10:EGFP+ cells
    PRJNA734348 (dome, dnmt1) embryo growth 4.3hpf, dome, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV)
    GSE158142 (14hpf) head baseline 14hpf, 10 somites, untreatment
    GSE158142 (16hpf) head baseline 16hpf, 14 somites, untreatment
    GSE158142 (1.5dpf) head baseline 1.5dpf, untreatment
    GSE150498 (nod2-|-, 1X DSS) intestine disease 6dpf, nod2-/-, 1X DSS
    GSE150498 (nod2-|-, 2X DSS+BZA) intestine disease 6dpf, nod2-/-, 2X DSS+BZA
    GSE150498 (DSS treated) intestine disease 6dpf, DSS treated
    GSE123241 (wild type) neuromast baseline 5dpf, wild type during sensory hair cell regeneration, lateral line sensory
    GSE123241 (fgf3 siblings) neuromast regeneration 5dpf, fgf3 siblings during sensory hair cell regeneration, lateral line sensory
    PRJNA668529 (3h) olfactory rosette disease 3mpf, intranasal 100ng r-Spike 3 hours
    PRJNA668529 (control) olfactory rosette baseline 3mpf, intranasal PBS
    GSE122680 (1.5dpf) retina baseline 1.5dpf, WT, untreatment
    GSE152982 (wild type) trunk baseline 1.25dpf, untreatment
    GSE131136 (all) trunk, skin baseline 5dpf, sox10:CRE positive cells from 5dpf and post-embryonic zebrafish trunks with and without thyroid hormone
    GSE158099 (runx1 -|-) whole body hematopoietic 16dpf, cd41:GFPlow-runx1-/-
    GSE176129 (pdgfrb-positive) whole body baseline 5dpf, FACS-isolated pdgfrb-positive cells

        After clicking the magnifying glass button, the clustering and expression information will be displayed below.